SCHEMBL7969533

SCHEMBL7969533

CCOC(Cc1ccc(OCC=C2c3sccc3CCc3ccsc32)cc1)C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 12/20 0.70
PPARA Q07869 17/20 0.64
PPARD Q03181 13/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965707 0.90 PPARA (0.70) PPARGPPARAPPARD
SCHEMBL6738252 0.82 PPARG (1.00) PPARGPPARAPPARD
SCHEMBL7965982 0.80 PPARA (0.57) PPARGPPARAPPARD
SCHEMBL7963791 0.80 PPARG (0.68) PPARGPPARAPPARD
SCHEMBL7953259 0.79 PPARA (0.54) PPARGPPARAPPARD
SCHEMBL6731786 0.78 PPARA (1.00) PPARGPPARAPPARD
SCHEMBL6750961 0.78 PPARG (0.57) PPARGPPARAPPARD
SCHEMBL7029285 0.77 PPARA (0.79) PPARGPPARAPPARD
SCHEMBL7029283 0.77 PPARA (0.79) PPARGPPARAPPARD
SCHEMBL6752637 0.77 PPARG (0.72) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300339-B1 USEFUL FOR THRERAPY AND/OR PROPHYLAXIS OF INSULIN RESISTANCE (TYPE 2 DIABETES), IMPAIRED GLUCOSE TOLERANCE, DYSLIPIDEMIA, HYPERTENSION, OBESITY, INSULIN RESISTANCE, HYPERGLYCEMIA, ATHEROSCLEROSIS, HYPERLIPIDEMIA, CORONARY ARTERY DISEASE NOVO NORDISK A/S (DK) 2001-10-09 US disclosed